Add BrightSurf on Google Email

Cancer Research UK


BJC press notice

A recent study by Cancer Research UK reveals that African-American cancer patients with inherited red blood cell conditions are 20% more likely to experience serious adverse events. This disparity may be attributed to the rigors of therapy and the disproportionately higher incidence of these disorders in the African-American population.

SourceCancer Research UK·JournalBritish Journal of Cancer·DateMar 19, 2019

British Journal of Cancer press notice

Two new studies published in the British Journal of Cancer reveal alarming breast cancer risks for women with false-positive screening results. Women who experience a first false-positive result have a two-fold risk of developing screen-detected or interval breast cancer later in life, while those with a second false-positive result fa...

SourceCancer Research UK·JournalBritish Journal of Cancer·DateDec 18, 2018

British Journal of Cancer press notice

Researchers have discovered that dasatinib sensitizes triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. Additionally, a systematic review and meta-analysis found an increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy.

SourceCancer Research UK·JournalBritish Journal of Cancer·DateNov 27, 2018

British Journal of Cancer press notice

A recent study published in the British Journal of Cancer found a positive association between type 2 diabetes and an increased risk of colorectal cancer (CRC) in men, with a moderately higher risk observed. In contrast, the association was weaker and not statistically significant for women. The study followed up over 87,000 women and ...

SourceCancer Research UK·JournalBritish Journal of Cancer·DateNov 6, 2018

Study shows potential to develop brain tumor liquid biopsies

Researchers have successfully detected brain tumor DNA in cerebrospinal fluid (CSF) using a cheap and widely available technique, opening up new possibilities for monitoring and treating brain tumors. The test has the potential to increase detection rates and provide more tailored treatment approaches for patients with brain tumors.

SourceCancer Research UK·JournalEMBO Molecular Medicine·DateNov 6, 2018

British Journal of Cancer press notice

Scientists have found that internal mammary chain irradiation and anthracycline-based chemotherapy increase cardiovascular disease risks, while a new test may detect colorectal cancer in primary care. Researchers also discovered circulating tumor cell clusters in human glioblastoma, suggesting a new target for treatment

SourceCancer Research UK·JournalBritish Journal of Cancer·DateJul 31, 2018

Belief in fake causes of cancer is rife

A survey found that over 40% of people in England believe stress, food additives, and electromagnetic frequencies cause cancer despite a lack of scientific evidence. Those with better knowledge of proven cancer causes were more likely to make healthier lifestyle choices.

SourceCancer Research UK·JournalEuropean Journal of Cancer·DateApr 25, 2018

Scientists halt breast cancer spread

Researchers found that restricting asparagine production in mice greatly reduced breast cancer's ability to spread, suggesting a potential new treatment approach. The study also suggests that dietary changes may help stop cancer from spreading and improve outcomes for patients.

SourceCancer Research UK·JournalNature·DateFeb 7, 2018

Health warnings on cigarettes could deter young people

A Cancer Research UK study found that health warnings on cigarette packaging can significantly reduce the likelihood of young people trying cigarettes. The study revealed that young people were around three times less likely to want to try cigarettes with a health warning compared to standard cigarettes.

SourceCancer Research UK·JournalNicotine & Tobacco Research·DateDec 11, 2017

Blood test could help predict skin cancer's return

Researchers found that a blood test for tumour DNA can predict the likelihood of aggressive skin cancer returning, with 33% of patients who tested positive being alive after five years compared to 65% of those who didn't. The study also revealed that patients with faults in genes BRAF and NRAS are more likely to experience a return wit...

SourceCancer Research UK·JournalAnnals of Oncology·DateDec 5, 2017